Trial Profile
Phase I trial of ATRA-IV [AR 623] and Depakote [valproate semisodium] in patients with advanced solid tumor malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs AR 623 (Primary) ; Valproate semisodium (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Oct 2005 New trial record.